Hye Jin An

970 total citations
25 papers, 735 citations indexed

About

Hye Jin An is a scholar working on Molecular Biology, Epidemiology and Physiology. According to data from OpenAlex, Hye Jin An has authored 25 papers receiving a total of 735 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Epidemiology and 7 papers in Physiology. Recurrent topics in Hye Jin An's work include Liver Disease Diagnosis and Treatment (5 papers), Adipose Tissue and Metabolism (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Hye Jin An is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Adipose Tissue and Metabolism (5 papers) and Peroxisome Proliferator-Activated Receptors (5 papers). Hye Jin An collaborates with scholars based in South Korea, United States and Japan. Hye Jin An's co-authors include Hae Young Chung, Dae Hyun Kim, Ki Wung Chung, Byung Pal Yu, Eun Kyeong Lee, Yeon Ja Choi, Min Hi Park, Kyoung Mi Moon, Bonggi Lee and Nam Deuk Kim and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and The Journals of Gerontology Series A.

In The Last Decade

Hye Jin An

25 papers receiving 727 citations

Peers

Hye Jin An

EPIDE

PHYSI

IMMUN

Eun Sil Kang South Korea

Marco Raffaele Italy

Vanessa Pitozzi Italy

Joe Eun Son South Korea

Si Young Cho South Korea

Lieqiang Xu China

Mi‐Young Jeong South Korea

Sun Ah Ham South Korea

Joo‐Hui Han South Korea

Taro Honma Japan

Eun Sil Kang South Korea

Hye Jin An

550 ×1.7

137 ×1.0

EPIDE

175 ×1.5

PHYSI

49 ×0.7

100 ×1.4

IMMUN

Citations per year, relative to Hye Jin An Hye Jin An (= 1×) peers Eun Sil Kang

Countries citing papers authored by Hye Jin An

Since Specialization

Citations

This map shows the geographic impact of Hye Jin An's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hye Jin An with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hye Jin An more than expected).

Fields of papers citing papers by Hye Jin An

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hye Jin An. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hye Jin An. The network helps show where Hye Jin An may publish in the future.

Co-authorship network of co-authors of Hye Jin An

This figure shows the co-authorship network connecting the top 25 collaborators of Hye Jin An. A scholar is included among the top collaborators of Hye Jin An based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hye Jin An. Hye Jin An is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lee, Bonggi, Hye Jin An, Dae Hyun Kim, et al.. (2022). SMP30-mediated synthesis of vitamin C activates the liver PPARα/FGF21 axis to regulate thermogenesis in mice. Experimental & Molecular Medicine. 54(11). 2036–2046. 6 indexed citations

Lee, Youngjoo, Hyae Young Kim, Byung‐Ho Nam, et al.. (2020). First-iGAP: A Randomized Placebo-Controlled Phase II Study of First-line Intercalated Gefitinib and Pemetrexed-Cisplatin Chemotherapy for Never-Smoker Lung Adenocarcinoma Patients. Clinical Lung Cancer. 21(6). e572–e582. 2 indexed citations

Chung, Ki Wung, Sugyeong Ha, Seong Min Kim, et al.. (2019). PPARα/β Activation Alleviates Age-Associated Renal Fibrosis in Sprague Dawley Rats. The Journals of Gerontology Series A. 75(3). 452–458. 17 indexed citations

Kim, Min Jo, Hye Jin An, Dae Hyun Kim, et al.. (2018). Novel SIRT1 activator MHY2233 improves glucose tolerance and reduces hepatic lipid accumulation in db/db mice. Bioorganic & Medicinal Chemistry Letters. 28(4). 684–688. 15 indexed citations

Lee, Jin Soo, Ji‐Youn Han, Youngjoo Lee, et al.. (2017). P3.02b-126 Clinical Activity of Olmutinib (HM61713) Used on a Compassionate IND Basis for Patients with Lung Adenocarcinoma (LADC) in Korea. Journal of Thoracic Oncology. 12(1). S1270–S1270. 3 indexed citations

Lee, Eun Kyeong, Dae Hyun Kim, Bonggi Lee, et al.. (2017). PPARα activation by MHY908 attenuates age-related renal inflammation through modulation of the ROS/Akt/FoxO1 pathway. Experimental Gerontology. 92. 87–95. 10 indexed citations

Kim, Dae Hyun, Seong Min Kim, Bonggi Lee, et al.. (2017). Effect of betaine on hepatic insulin resistance through FOXO1-induced NLRP3 inflammasome. The Journal of Nutritional Biochemistry. 45. 104–114. 52 indexed citations

Chung, Ki Wung, Yeon Ja Choi, Hye Jin An, et al.. (2017). The critical role played by endotoxin-induced liver autophagy in the maintenance of lipid metabolism during sepsis. Autophagy. 13(7). 1113–1129. 72 indexed citations

Lee, Youngjoo, Ji‐Youn Han, Sung Ho Moon, et al.. (2017). Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status. Cancer Research and Treatment. 49(4). 981–989. 13 indexed citations

10.

Moon, Kyoung Mi, Bonggi Lee, Dae Hyun Kim, et al.. (2017). Thio-barbiturate-derived compounds are novel antioxidants to prevent LPS-induced inflammation in the liver. Oncotarget. 8(53). 91662–91673. 8 indexed citations

11.

Lee, Bonggi, Kyoung Mi Moon, Yeojin Park, et al.. (2017). 2-(3, 4-dihydroxybenzylidene)malononitrile as a novel anti-melanogenic compound. Oncotarget. 8(53). 91481–91493. 19 indexed citations

12.

An, Hye Jin, Bonggi Lee, Seong Min Kim, et al.. (2017). A PPAR Pan Agonist, MHY2013 Alleviates Age-Related Hepatic Lipid Accumulation by Promoting Fatty Acid Oxidation and Suppressing Inflammation. Biological and Pharmaceutical Bulletin. 41(1). 29–35. 18 indexed citations

13.

Lee, Bonggi, Kyoung Mi Moon, Seong Jin Kim, et al.. (2016). (Z)‐5‐(2,4‐Dihydroxybenzylidene)thiazolidine‐2,4‐dione Prevents UVB‐Induced Melanogenesis and Wrinkle Formation through Suppressing Oxidative Stress in HRM‐2 Hairless Mice. Oxidative Medicine and Cellular Longevity. 2016(1). 2761463–2761463. 16 indexed citations

14.

Park, Min Hi, Dae Hyun Kim, Min Jo Kim, et al.. (2015). Effects of MHY908, a New Synthetic PPARα/γ Dual Agonist, on Inflammatory Responses and Insulin Resistance in Aged Rats. The Journals of Gerontology Series A. 71(3). 300–309. 22 indexed citations

15.

Chung, Ki Wung, Eun Kyeong Lee, Dae Hyun Kim, et al.. (2015). Age‐related sensitivity to endotoxin‐induced liver inflammation: Implication of inflammasome/IL‐1β for steatohepatitis. Aging Cell. 14(4). 524–533. 35 indexed citations

16.

An, Hye Jin, et al.. (2015). Preparation of 2-(t-butyl)dimethylsilyl-3,3-difluoropropenones via acylation reactions of 1-(t-butyl)dimethylsilyl-2,2-difluoroethenylstannane. Journal of Fluorine Chemistry. 179. 129–133. 5 indexed citations

17.

Kim, Dae Hyun, Min Hi Park, Eun Kyeong Lee, et al.. (2014). The roles of FoxOs in modulation of aging by calorie restriction. Biogerontology. 16(1). 1–14. 33 indexed citations

18.

Kim, Dae Hyun, Min Hi Park, Yeon Ja Choi, et al.. (2013). Molecular Study of Dietary Heptadecane for the Anti-Inflammatory Modulation of NF-kB in the Aged Kidney. PLoS ONE. 8(3). e59316–e59316. 73 indexed citations

19.

Kim, So Ra, Yu Ri Jung, Hye Jin An, et al.. (2013). Anti-Wrinkle and Anti-Inflammatory Effects of Active Garlic Components and the Inhibition of MMPs via NF-κB Signaling. PLoS ONE. 8(9). e73877–e73877. 121 indexed citations

20.

Kim, So Ra, Yu Ri Jung, Dae Hyun Kim, et al.. (2013). Caffeic acid regulates LPS-induced NF-κB activation through NIK/IKK and c-Src/ERK signaling pathways in endothelial cells. Archives of Pharmacal Research. 37(4). 539–547. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact